drugset / Trial / NCT01353508
Sodium Excretion of LCZ696 in Patients With Hypertension; Heart Failure and Healthy Volunteers
RandomizedCrossoverQuadruple-blindTreatment
Summary
Assess mechanism of action of LCZ696 related to sodium excretion.
Timeline
- Start
- 2011-03
- Primary completion
- 2012-08
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LCZ696 | Unknown | 200 mg | — |
| Subject | LCZ696 | Unknown | 400 mg | — |
| Subject | Valsartan | Small molecule | 160 mg | — |
| Subject | Valsartan | Small molecule | 320 mg | — |